The mix-up at a Baltimore manufacturing plant forced regulators to delay authorization of the plant’s production lines and prompted an FDA investigation.
News on the Net -- Childrens Health Defense, Bio and Archives--April 2, 2021
| Comments | Reader Friendly | Subscribe | Email Us
View Comments
News from around the world